Kei Watase
Yushima, 1138510, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Subcellular localization and ER-mediated cytotoxic function of α1A and α1ACT in spinocerebellar ataxia type 6.
Journal: Biochemical and biophysical research communications
Published: December 20, 2023
Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation.
Journal: Brain : a journal of neurology
Published: March 05, 2019
Developmental YAPdeltaC determines adult pathology in a model of spinocerebellar ataxia type 1.
Journal: Nature communications
Published: April 04, 2017
Alternative splicing in the C-terminal tail of Cav2.1 is essential for preventing a neurological disease in mice.
Journal: Human molecular genetics
Published: December 26, 2016
Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice.
Journal: Human molecular genetics
Published: June 30, 2016
RpA1 ameliorates symptoms of mutant ataxin-1 knock-in mice and enhances DNA damage repair.
Journal: Human molecular genetics
Published: March 28, 2016
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Journal: Autophagy
Published: January 23, 2016
Loss of MyD88 alters neuroinflammatory response and attenuates early Purkinje cell loss in a spinocerebellar ataxia type 6 mouse model.
Journal: Human molecular genetics
Published: April 08, 2015
Molecular targeted therapy towards neurological disorders
Journal: Nihon rinsho. Japanese journal of clinical medicine
Published: March 22, 2013
Development of Purkinje cell degeneration in a knockin mouse model reveals lysosomal involvement in the pathogenesis of SCA6.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 12, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026